首页> 外文期刊>Cadernos de Saúde Pública >Análise da adequa??o das propagandas de medicamentos dirigidas à categoria médica distribuídas no Sul do Brasil
【24h】

Análise da adequa??o das propagandas de medicamentos dirigidas à categoria médica distribuídas no Sul do Brasil

机译:分析在巴西南部分发的针对医疗类别的药品广告是否足够

获取原文
       

摘要

Drug advertisements for prescription drugs gathered from private clinics and hospitals in southern Brazil were analyzed. None of the 127 advertisement inserts that were analyzed complied with all the criteria specified by Brazilian legislation. The official Brazilian generic drug name was present in 95% of the advertisements, but always in finer and/or fainter print. With regard to the "WHO ethical criteria for medicinal drug promotion" the study showed that only 59% of the advertisement inserts declared the product composition and only 43% provided information on precautions, and in most of these cases (73%), the precautions were in fine print and difficult to read. Most of the advertisements declared the product dosage in more properly-sized print. The main advertising claims were efficacy, safety, faster action, and high tolerability. In conclusion, the analysis demonstrated that most advertisements fail to comply with either the Brazilian legislation on medicinal products and/or the WHO ethical criteria for medicinal drug promotion. To improve this situation it thus seems necessary to develop more effective instruments to monitor quality of information provided to prescribers by the drug advertisers.
机译:分析了从巴西南部的私人诊所和医院收集的处方药广告。经过分析的127个广告插入物中,没有一个符合巴西法律规定的所有标准。巴西官方仿制药的官方名称出现在95%的广告中,但始终以精美和/或淡淡的字体出现。关于“世卫组织促进药物使用的道德标准”,研究表明,只有59%的广告插页中声明了产品成分,只有43%的成分提供了预防措施的信息,在大多数情况下(73%),这些预防措施印刷精美,难以阅读。大多数广告都以更合适的尺寸宣告了产品剂量。广告的主要宣称是功效,安全性,更快的动作和较高的耐受性。总之,分析表明,大多数广告均不符合巴西有关药品的法律和/或WHO宣传药品的道德标准。因此,为了改善这种情况,似乎有必要开发更有效的手段来监测药品广告商提供给处方者的信息的质量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号